Dov Sagi

THCG, Inc. is currently providing a limited level of investment banking and other financial advisory services through Tower Hill. Prior to November 1, 1999, the Company was a closed-end management investment company with three business focuses: investing in start-up and early stage development companies; operating an investment vehicle that specialized in bridge financing to small and medium-sized companies; and providing accounts receivable-based commercial financing, or factoring and related services. During 2000, the Company provided a combination of venture funding, venture development and venture banking services to its partner companies, comprised of Internet and technology companies in which it acquired direct or indirect equity interests as well as to third parties to which it provided services for fees. THCG is located in New York, NY.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Rogerscasey, Inc. offers investment consulting services and software solutions. It offers performance reporting, target-date funds, and master manager solutions. The company is founded in 1968 and is headquartered in Darien, CT.